CME Group Inc. (CME) Institutional Ownership & Insider Trading

1,700 institutions reported holding CME Group Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 25 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason

CMECME Group Inc.Follow CME — free

Financial Data & Stock Exchanges · Financials

—

Price chart with a free account

Market cap: 109.9B
P/E TTM: 25.1
Dividend yield: 1.6%
52-week: —
Next earnings: 2 Feb, in 101 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

1,700 institutions held 89.5% of the shares. Across filers that reported both quarters, shares held changed -1.7%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	1,700	322	-1.7%	578	112	594	202
Mar 26	1,778	321	+1.1%	615	130	536	77
Dec 25	1,684	322	-3.1%	596	86	477	63
Sep 25	1,613	325	+2.0%	517	82	486	89
Jun 25	1,627	321	-0.7%	587	124	435	63
Mar 25	1,546	316	+0.9%	490	145	477	61
Dec 24	1,447	318	-2.2%	473	90	398	57
Sep 24	1,350	309	-3.0%	421	92	461	65

CME Group Inc. — questions

Who owns CME Group Inc. stock?: 1,700 institutions reported CME Group Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (8.5%), VANGUARD CAPITAL MANAGEMENT LLC (6.6%), STATE STREET CORP (4.5%).
Are CME Group Inc. insiders buying or selling?: 25 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from CME Group Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.